ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesChapter 17: Congenital malformations and chromosomal abnormalitiesQ33

Q33

Non-billable

Congenital malformations of lung

Chapter 17:Congenital malformations and chromosomal abnormalities

BILLABLE STATUSNo
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 Q33 is a used to indicate a diagnosis of congenital malformations of lung.

Key Diagnostic Point:

Q33 encompasses a variety of congenital malformations of the lung, which are structural abnormalities present at birth. These malformations can include conditions such as congenital cystic adenomatoid malformation, pulmonary hypoplasia, and bronchogenic cysts, among others. The clinical significance of these conditions can vary widely, ranging from asymptomatic cases that may resolve spontaneously to severe respiratory distress requiring immediate intervention. Accurate coding is crucial for proper diagnosis, treatment planning, and tracking of these congenital anomalies in patient populations.

  • The usage of Q33 codes is essential in pediatric care, particularly in neonatology and pediatric pulmonology, where early identification and management of lung malformations can significantly affect patient outcomes. Healthcare providers should be aware of the specific conditions included under this category to ensure appropriate coding and billing practices. Additionally, understanding the implications of these congenital malformations can help in counseling families regarding potential long-term health issues and the need for ongoing monitoring and care.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Variety of conditions covered
  • Need for precise documentation
  • Potential for associated complications

Audit Risk Factors

  • Inadequate documentation of specific malformations
  • Misclassification of congenital conditions
  • Failure to capture associated respiratory issues

Specialty Focus

Medical Specialties

Pediatrics

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Pulmonology

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Related CPT Codes

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The clinical impact of Q33 is significant, as early detection and management of congenital lung malformations can lead to improved health outcomes and quality of life for affected individuals. These conditions can influence population health trends, particularly in neonatal care, where timely interventions can reduce morbidity and mortality rates. Furthermore, tracking the incidence of congenital lung malformations can inform public health initiatives and resource allocation for pediatric healthcare.
Administratively, accurate coding under Q33 is crucial for healthcare providers to ensure appropriate reimbursement and to support quality measures related to congenital conditions. This coding category also plays a role in research and epidemiological studies, helping to identify risk factors and outcomes associated with congenital lung malformations, ultimately guiding clinical practices and policy development in pediatric healthcare.

ICD-9 vs ICD-10

The clinical impact of Q33 is significant, as early detection and management of congenital lung malformations can lead to improved health outcomes and quality of life for affected individuals. These conditions can influence population health trends, particularly in neonatal care, where timely interventions can reduce morbidity and mortality rates. Furthermore, tracking the incidence of congenital lung malformations can inform public health initiatives and resource allocation for pediatric healthcare. Administratively, accurate coding under Q33 is crucial for healthcare providers to ensure appropriate reimbursement and to support quality measures related to congenital conditions. This coding category also plays a role in research and epidemiological studies, helping to identify risk factors and outcomes associated with congenital lung malformations, ultimately guiding clinical practices and policy development in pediatric healthcare.

Reimbursement & Billing Impact

reimbursement and to support quality measures related to congenital conditions. This coding category also plays a role in research and epidemiological studies, helping to identify risk factors and outcomes associated with congenital lung malformations, ultimately guiding clinical practices and policy development in pediatric healthcare.

Resources

Clinical References

  • •
    Official ICD-10 Guidelines for Q33

Coding & Billing References

  • •
    Official ICD-10 Guidelines for Q33

Frequently Asked Questions

What conditions are included in Q33?

Q33 includes congenital malformations such as congenital cystic adenomatoid malformation, pulmonary hypoplasia, bronchogenic cysts, and other structural lung abnormalities present at birth.

When should I use Q33 codes?

Q33 codes should be used when documenting congenital lung malformations diagnosed in newborns or infants, particularly when these conditions are identified through imaging or clinical evaluation.

What documentation is required for Q33?

Documentation for Q33 should include detailed clinical findings, imaging results, and any relevant family history of congenital conditions. Clear descriptions of the malformation and its impact on the patient's health are also necessary.